Nagareyama, Japan

Kazutoshi Horie

This inventor holds 1 USPTO granted patent. Top assignee: Drug Delivery System Institute, Ltd.. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazutoshi Horie. Retrieved from https://idiyas.com/inventor/kazutoshi-horie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazutoshi Horie: Innovator in Drug Delivery Systems

Introduction

Kazutoshi Horie is a notable inventor based in Nagareyama, Japan. He has made significant contributions to the field of drug delivery systems, particularly through his innovative research and development efforts.

Latest Patents

Horie holds a patent for formamido and carboxyamido compounds that can be retained in the brain. This invention has the potential to enhance the effectiveness of drug delivery to the central nervous system.

Career Highlights

Kazutoshi Horie is associated with the Drug Delivery System Institute, Ltd., where he continues to work on advancing drug delivery technologies. His expertise in this area has positioned him as a key figure in the development of new therapeutic methods.

Collaborations

Horie collaborates with esteemed colleagues such as Hiroshi Ishihara and Toyoaki Ishikura. Their combined efforts contribute to the innovative research being conducted at their institute.

Conclusion

Kazutoshi Horie's work in drug delivery systems exemplifies the impact of innovative thinking in medicine. His contributions are paving the way for advancements that could significantly improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…